Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment [Editorial] (2019)
Source: European journal of nuclear medicine and molecular imaging. Unidade: FM
Subjects: NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA, TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE PÓSITRON, BRAQUITERAPIA, PROSTATECTOMIA, QUIMIOTERAPIA
ABNT
COSTA, Larissa Bastos et al. Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment [Editorial]. European journal of nuclear medicine and molecular imaging. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1007/s00259-019-04328-1. Acesso em: 05 jun. 2024. , 2019APA
Costa, L. B., Queiroz, M. A., Barbosa, F. de G., Nunes, R. F., Marin, J. F. G., Dzik, C., & Buchpiguel, C. A. (2019). Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment [Editorial]. European journal of nuclear medicine and molecular imaging. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1007/s00259-019-04328-1NLM
Costa LB, Queiroz MA, Barbosa F de G, Nunes RF, Marin JFG, Dzik C, Buchpiguel CA. Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment [Editorial] [Internet]. European journal of nuclear medicine and molecular imaging. 2019 ; 46( 7): 1576-1577.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1007/s00259-019-04328-1Vancouver
Costa LB, Queiroz MA, Barbosa F de G, Nunes RF, Marin JFG, Dzik C, Buchpiguel CA. Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment [Editorial] [Internet]. European journal of nuclear medicine and molecular imaging. 2019 ; 46( 7): 1576-1577.[citado 2024 jun. 05 ] Available from: https://doi.org/10.1007/s00259-019-04328-1